{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T12:56:16Z","timestamp":1770296176100,"version":"3.49.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2016\/23\/B\/NZ7\/01063"],"award-info":[{"award-number":["2016\/23\/B\/NZ7\/01063"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.biopha.2021.111952","type":"journal-article","created":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T06:26:40Z","timestamp":1627280800000},"page":"111952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Metabolic benefits of novel histamine H3 receptor ligands in the model of excessive eating: The importance of intrinsic activity and pharmacokinetic properties"],"prefix":"10.1016","volume":"142","author":[{"given":"Kamil","family":"Mika","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Szafarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Bednarski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamil","family":"Kuder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Szczepa\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Pociecha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bartosz","family":"Pomierny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Kie\u0107-Kononowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Sapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Kota\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.111952_bib1","unstructured":"\u3008https:\/\/www.who.int\/health-topics\/obesity\u3009. Last accessed 03.02.2021."},{"key":"10.1016\/j.biopha.2021.111952_bib2","series-title":"Obesity Antenatal Disorders for the MRCOG and Beyond","author":"Jivraj","year":"2016"},{"issue":"2","key":"10.1016\/j.biopha.2021.111952_bib3","first-page":"288","article-title":"Histamine: intraventricular injection suppresses ingestive behavior of the cat","volume":"206","author":"Clineschmidt","year":"1973","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"issue":"4","key":"10.1016\/j.biopha.2021.111952_bib4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2165\/00003495-198019040-00002","article-title":"Drug-induced weight gain","volume":"19","author":"Kalucy","year":"1980","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.biopha.2021.111952_bib5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1124\/jpet.110.171306","article-title":"The histamine H3 receptor and eating behavior","volume":"336","author":"Passani","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2021.111952_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mam.2012.10.005","article-title":"Obesity pharmacotherapy: what is next?","volume":"34","author":"Colon-Gonzalez","year":"2013","journal-title":"Mol. Asp. Med."},{"issue":"7","key":"10.1016\/j.biopha.2021.111952_bib7","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2174\/1871527318666190703094846","article-title":"Central histamine, the H3-receptor and obesity therapy","volume":"18","author":"Diaz","year":"2019","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.biopha.2021.111952_bib8","first-page":"1","article-title":"Dual-targetting approach on histamine H3 and sigma-1 receptor ligands as promising pharmacological tools in the treatment of CNS-linked disorders","volume":"27","author":"Szczepa\u0144ska","year":"2020","journal-title":"Curr. Med. Chem."},{"issue":"8","key":"10.1016\/j.biopha.2021.111952_bib9","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00210-018-1516-2","article-title":"The histamine H3 receptor inverse agonist pitolisant reduces body weight in obese mice","volume":"391","author":"Kota\u0144ska","year":"2018","journal-title":"Naunyn Schmiede. Arch. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111952_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejmech.2018.04.043","article-title":"Synthesis and biological activity of novel tert-butyl and tert-pentylphenoxyalkyl piperazine derivatives as histamine H3R ligands","volume":"152","author":"Szczepa\u0144ska","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2021.111952_bib11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bcp.2019.07.006","article-title":"KSK19 - novel histamine H3 receptor ligand reduces body weight in diet induced obese mice","volume":"168","author":"Kota\u0144ska","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111952_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113041","article-title":"Structural modifications in the distal, regulatory region of histamine H3 receptor antagonists leading to the identification of a potent anti-obesity agent","volume":"213","author":"Szczepa\u0144ska","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2021.111952_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103071","article-title":"Structural modifications and in vitro pharmacological evaluation of 4-pyridyl-piperazine derivatives as an active and selective histamine H3 receptor ligand","volume":"91","author":"Szczepa\u0144ska","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2021.111952_bib14","article-title":"The anorexigenic effects of metformin involve increases in hypothalamic leptin receptor expression","volume":"60","author":"Aubert","year":"2011","journal-title":"Metabolizm"},{"key":"10.1016\/j.biopha.2021.111952_bib15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fnins.2017.00050","article-title":"Metabolic and cardiovascular benefits and risks of EMD386088-A 5-HT6 receptor partial agonist and dopamine transporter inhibitor","volume":"11","author":"Kota\u0144ska","year":"2017","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2021.111952_bib16","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s11011-017-0175-1","article-title":"Idalopirdine, a selective 5-HT6 receptor antagonist, reduces food intake and body weight in a model of excessive eating","volume":"33","author":"Kota\u0144ska","year":"2018","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.biopha.2021.111952_bib17","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s11011-015-9736-3","article-title":"Idalopirdine \u2013 a small molecule antagonist of 5-HT6 with therapeutic potential against obesity","volume":"30","author":"Dudek","year":"2015","journal-title":"Metab. Brain Dis."},{"issue":"10","key":"10.1016\/j.biopha.2021.111952_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141327","article-title":"A comparison of the anorectic effect and safety of the alpha2-adrenoceptor ligands guanfacine and yohimbine in rats with diet-induced obesity","volume":"10","author":"Dudek","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.biopha.2021.111952_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229806","article-title":"KD \u2013 64 a new selective A2a adenosine receptor antagonist has anti-inflammatory activity but contrary to the non-selective antagonist \u2013 caffeine does not reduce diet-induced obesity in mice","volume":"15","author":"Kota\u0144ska","year":"2020","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.biopha.2021.111952_bib20","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.cgh.2006.09.014","article-title":"Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers","volume":"4","author":"Limburg","year":"2006","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111952_bib21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/157488907782411792","article-title":"Therapeutic approach of histamine H3 receptors in obesity","volume":"2","author":"Masaki","year":"2007","journal-title":"Recent Pat. CNS Drug Discov."},{"issue":"23\u201324","key":"10.1016\/j.biopha.2021.111952_bib22","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S1359-6446(05)03625-1","article-title":"Keynote review. Histamine H3 receptor antagonists reach out for the clinic","volume":"10","author":"Celanire","year":"2005","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.biopha.2021.111952_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1124\/mi.6.2.5","article-title":"Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disorders","volume":"6","author":"Esbenshade","year":"2006","journal-title":"Mol. Interv."},{"issue":"10","key":"10.1016\/j.biopha.2021.111952_bib24","first-page":"1190","article-title":"H3 receptor antagonists\/inverse agonists as anti-obesity agents","volume":"4","author":"Hancock","year":"2003","journal-title":"Curr. Opin. Investig. Drugs"},{"issue":"4","key":"10.1016\/j.biopha.2021.111952_bib25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.tins.2014.02.007","article-title":"The other side of the histamine H3 receptor","volume":"37","author":"Ellenbroek","year":"2014","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.biopha.2021.111952_bib26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/bph.12429","article-title":"The expression and function of histamine H3 receptors in pancreatic beta cells","volume":"171","author":"Nakamura","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111952_bib27","first-page":"1","article-title":"Hypolipemic effects of histamine is due to inhibition of VLDL secretion from the liver: involvement of both H1 and H2 \u2013 receptors","volume":"24","author":"Nikfar","year":"2020","journal-title":"Arch. Physiol. Biochem."},{"issue":"14","key":"10.1016\/j.biopha.2021.111952_bib28","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.3390\/ijms20143420","article-title":"The 1,3,5-triazine derivatives as innovative chemical family of 5-HT6 serotonin receptor agents with therapeutic perspectives for cognitive impairment","volume":"20","author":"Latacz","year":"2019","journal-title":"IJMS"},{"issue":"23\u201324","key":"10.1016\/j.biopha.2021.111952_bib29","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1016\/j.bmc.2018.11.010","article-title":"Optimization and preclinical evaluation of novel histamine H3receptor ligands: acetyl and propionyl phenoxyalkyl piperazine derivatives","volume":"26","author":"Szczepa\u0144ska","year":"2018","journal-title":"Bioorg. Med. Chem."},{"issue":"10","key":"10.1016\/j.biopha.2021.111952_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23102529","article-title":"Computer-aided studies for novel arylhydantoin 1,3,5-triazine derivatives as 5-HT\u2086 serotonin receptor ligands with antidepressive-like, anxiolytic and antiobesity action in vivo","volume":"23","author":"Kurczab","year":"2018","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.biopha.2021.111952_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1742-7843.2005.pto_179.x","article-title":"How palatable food disrupts appetite regulation","volume":"97","author":"Erlanson-Albertsson","year":"2005","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.biopha.2021.111952_bib32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev.psych.51.1.255","article-title":"Food intake and the regulation of body weight","volume":"51","author":"Woods","year":"2000","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.biopha.2021.111952_bib33","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1172\/JCI200418917","article-title":"Inactivation of fatty acid transport protein 1 prevents fat\u2010induced insulin resistance in skeletal muscle","volume":"113","author":"Kim","year":"2004","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2021.111952_bib34","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1210\/en.2003-0456","article-title":"Study of the alteration of gene expression in adipose tissue of diet\u2010induced obese mice by microarray and reverse transcription\u2010polymerase chain reaction analyses","volume":"144","author":"Moraes","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopha.2021.111952_bib35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cca.2012.12.007","article-title":"Role of leptin and adiponectin in insulin resistance","volume":"417","author":"Yadav","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.biopha.2021.111952_bib36","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3390\/nu11061197","article-title":"Evaluating the impact of different hypercaloric diets on weight gain, insulin resistance, glucose intolerance, and its comorbidities in rats","volume":"11","author":"Melo","year":"2019","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.biopha.2021.111952_bib37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2337\/diaspect.17.3.183","article-title":"Glucose metabolism and regulation: beyond insulin and glucagon","volume":"17","author":"Aronoff","year":"2004","journal-title":"Diabetes Spectr."},{"issue":"1","key":"10.1016\/j.biopha.2021.111952_bib38","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1463-1326.2011.01454.x","article-title":"Physiologic action of glucagon on liver glucose metabolism","volume":"13","author":"Ramnanan","year":"2011","journal-title":"Diabetes Obes."},{"key":"10.1016\/j.biopha.2021.111952_bib39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1210\/jcem-38-1-77","article-title":"Characterization of the glucagon response to hypoglycemia in man","volume":"38","author":"Gerich","year":"1984","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2021.111952_bib40","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJM198507253130405","article-title":"Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus","volume":"313","author":"Cryer","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2021.111952_bib41","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2337\/db10-1594","article-title":"Glucagon as a critical factor in the pathology of diabetes","volume":"60","author":"Edgerton","year":"2011","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.biopha.2021.111952_bib42","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.diabres.2004.10.005","article-title":"Influence of exogenous insulin on C-peptide levels in subjects with type 2 diabetes","volume":"68","author":"Albareda","year":"2005","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.biopha.2021.111952_bib43","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.2174\/0929867327666200806103144","article-title":"Dual-targeting approach on histamine H3 and sigma-1 receptor ligands as promising pharmacological tools in the treatment of CNS-linked disorders","volume":"28","author":"Szczepa\u0144ska","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2021.111952_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2017.10.013","article-title":"A behavioral and pharmacological characterization of palatable diet alternation in mice","volume":"163","author":"Moore","year":"2017","journal-title":"Pharmacol. Biochem. Behav."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221007344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221007344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:19:48Z","timestamp":1760098788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221007344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":44,"alternative-id":["S0753332221007344"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111952","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic benefits of novel histamine H3 receptor ligands in the model of excessive eating: The importance of intrinsic activity and pharmacokinetic properties","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111952","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111952"}}